Quality use of medicines: the postmenopausal woman with osteoporosis

  • Andy Gray University of Natal
  • Julia Botha University of Natal
  • Deon Hoffman Universitv of Natal

Abstract

Guidelines for the management of any condition suffer the ravages of time and can be challenged even by the publication of a single study. This may well apply to any guidelines that include hormone replacement therapy (HRT), such as the Osteoporosis Clinical Guideline published in 2000 by the South African Medical Association. Nothing that 'reliable comparative data on the various drugs registered for the treatment of osteoporosis are not available', the Osteoporosis Working Group attempted to guide clinicians' drug choices.

Author Biographies

Andy Gray, University of Natal
Department of Experimental and Clinical Pharmacology Nelson R Mandela School of Medicine
Julia Botha, University of Natal
Department of Experimental and Clinical Pharmacology Nelson R Mandela School of Medicine
Deon Hoffman, Universitv of Natal
Department of Experimental and Clinical Pharmacology Nelson R Mandela School of Medicine
Issue
Vol 45 No 5 (2003)
Section
CPD
By submitting manuscripts to SAFP, authors of original articles are assigning copyright to the South African Academy of Family Physicians. Copyright of review articles are assigned to the Publisher, Medpharm Publications (Pty) Ltd, unless otherwise specified. Authors may use their own work after publication without written permission, provided they acknowledge the original source. Individuals and academic institutions may freely copy and distribute articles published in SAFP for educational and research purposes without obtaining permission.